Bile Exosomal miR-182/183–5p Increases Cholangiocarcinoma Stemness and Progression by Targeting HPGD and Increasing PGE2 Generation

Exosomes in bile and sera from cholangiocarcinoma, pancreatic cancer, and common bile duct stone were identified and quantified by TEM, NTA, and nanoFCM.